Previous Close | 27.74 |
Open | 28.45 |
Bid | 27.79 x 200 |
Ask | 27.84 x 200 |
Day's Range | 27.18 - 28.78 |
52 Week Range | 12.75 - 44.32 |
Volume | |
Avg. Volume | 1,693,645 |
Market Cap | 5.208B |
Beta (5Y Monthly) | 1.03 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
The latest analyst coverage could presage a bad day for BridgeBio Pharma, Inc. ( NASDAQ:BBIO ), with the analysts...
BridgeBio Pharma ( NASDAQ:BBIO ) First Quarter 2024 Results Key Financial Results Revenue: US$211.1m (up by US$209.3m...
BridgeBio Pharma (BBIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.